{"nct_id":"NCT05255601","title":"A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-09-13","start_date_type":"ACTUAL","primary_completion_date":"2028-07-05","primary_completion_date_type":"ESTIMATED","completion_date":"2028-07-05","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["BMY"]}